These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17320655)

  • 1. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
    Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
    Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
    Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Itoh N; Tsukamoto T
    Int J Urol; 2006 Mar; 13(3):265-70. PubMed ID: 16643621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.
    Vilà MR; Nicolás A; Morote J; de I; Meseguer A
    Cancer; 2000 Jul; 89(1):152-64. PubMed ID: 10897012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
    Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
    Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
    BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of novel genes differentially expressed in human renal cell carcinoma by suppression subtractive hybridization].
    Ai JK; Huang X; Wang YJ; Bai Y; Lu YQ; Ye XJ; Xin DQ; Na YQ; Zhang ZW; Guo YL
    Ai Zheng; 2002 Oct; 21(10):1065-9. PubMed ID: 12508644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
    Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
    Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
    Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
    Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of brain‑type fatty acid binding protein for cell-biological processes in human renal carcinoma cells.
    Tölle A; Krause H; Miller K; Jung K; Stephan C
    Oncol Rep; 2011 May; 25(5):1307-12. PubMed ID: 21399875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
    Tölle A; Suhail S; Jung M; Jung K; Stephan C
    BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.